Plant Summary

  Plant Information

TCMBank_ID:

TCMBANKHE008754

YEM_ID:

YEM-818

ID:

TCMBANKHE008754/YEM-818

植物拉丁名:

Salvia trijuga|Salvia trijuga Diels
显示图片

功能与主治:

To quicken blood and regulate menstruation, dispel stasis and engender flesh, boost kidney and quiet spirit./Menstrual disorder, dysmenorrhea, menstrual block, flooding, kidney vacuity lumbago, impotence, insomnia, frequent dreaming, knocks and falls.

药用植物名:

三叶鼠尾草

药名:

三叶鼠尾

来源:

云南民族药物志：第四卷

药用部位:

root

使用民族:

藏族

TCM_ID_id:

3056

   植物对应的化合物
化合物ID 化合物名 别名 分子式 分子质量 Smiles
TCMBANKIN000088 cryptotanshinone NCI60_031208; CTS; 4733-35-1; A822990; C19H22O3; ZINC02109876; SMR000387041; (1R)-1,6,6-trimethyl-2,7,8,9-tetrahydro-1H-naphtho[8,7-g][1]benzoxole-10,11-dione; (1R)-1,6,6-trimethyl-2,3a,7,8,9,11a-hexahydro-1H-naphtho[1,2-g][1]benzofuran-10,11-dione; (1R)-1,6,6-trimethyl-2,7,8,9-tetrahydro-1H-naphtho[8,7-g]benzofuran-10,11-quinone; (1R)-1,6,6-trimethyl-2,3a,7,8,9,11a-hexahydro-1H-naphtho[1,2-g]benzofuran-10,11-dione; NCGC00163650-01; BB_NC-1574; Phenanthro[1,2-b]furan-10,11-dione, 1,2,6,7,8,9-hexahydro-1,6,6-trimethyl-, (1R)-; MolPort-006-823-903; (1R)-1,6,6-trimethyl-1,2,3a,6,7,8,9,11a-octahydrophenanthro[1,2-b]furan-10,11-dione; MLS001049002; 35825-57-1; DTXSID0044072; (1R)-1,6,6-trimethyl-2,7,8,9-tetrahydro-1H-naphtho[8,7-g]benzofuran-10,11-dione; (-)-Cryptotanshinone; Phenanthro(1,2-b)furan-10,11-dione, 1,2,6,7,8,9-hexahydro-1,6,6-trimethyl-, (R)-; SPECTRUM1505812 C19H20O3 296.36 CC1COC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCCC4(C)C
TCMBANKIN000434 methyltanshinonate Methuyl tanshinonate; (?)-Methyl tanshinonate; FT-0628808; Methyl 1,6-dimethyl-10,11-dioxo-6,7,8,9,10,11-hexahydrophenanthro[1,2-b]furan-6-carboxylate #; AC1LDQ9J; METHYL 6,14-DIMETHYL-16,17-DIOXO-12-OXATETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-1(10),2(7),8,11(15),13-PENTAENE-6-CARBOXYLATE; Phenanthro[1,2-b]furan-6-carboxylic acid, 6,7,8,9,10,11-hexahydro-1,6-dimethyl-10,11-dioxo-, methyl ester; methyl tanshinonate; 135355-72-5; YFDKIHAZVQFLRC-UHFFFAOYSA-N; methyl 1,6-dimethyl-10,11-dioxo-8,9-dihydro-7H-naphtho[1,2-g][1]benzofuran-6-carboxylate; methyl 6,14-dimethyl-16,17-dioxo-12-oxatetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadeca-1(10),2(7),8,11(15),13-pentaene-6-carboxylate; Methyltanshinonate; SCHEMBL16152293 C20H18O5 338.4 g/mol CC1=COC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCCC4(C)C(=O)OC
TCMBANKIN019902 3, 4-dihydroxybenzoicacid4-O-(4′-O-methyl)-β-D-glucopyranoside
TCMBANKIN020151 l-homoserine KB-211151; TC-152476; DTXSID00659274; (R)-3-AMINO-4-HYDROXYBUTYRIC ACID HYDROCHLORIDE; I04-1166; 123053-31-6; L-Homoserine--hydrogen chloride (1/1); FT-0605337; l-beta-homoserine hcl; H72H151; (s)-homoserinehcl; l-beta-homoserine hydrochloride; (S)-2-Amino-4-hydroxybutanoic acid hydrochloride; CTK8B9962; ANW-63731; AKOS015892796; BG00903522; PubChem11050; AK-72527; h-beta-homoser-oh hcl; (S)-Homoserine hydrochloride; h-ser-(c*ch2)oh 2cl; A-8355; L-Homoserine hydrochloride; AX8220589 C4H10ClNO3 155.58 g/mol C(CO)C(C(=O)O)N.Cl
TCMBANKIN023663 Methylenetanshinquinone Tanshinquinone, methylene-; 1-Methyl-6-methylene-6,7,8,9-tetrahydrophenanthro[1,2-b]furan-10,11-dione; 1-methyl-6-methylidene-8,9-dihydro-7H-naphtho[8,7-g][1]benzoxole-10,11-dione; 1-methyl-6-methylene-8,9-dihydro-7H-naphtho[8,7-g]benzofuran-10,11-quinone; 67656-29-5; Phenanthro(1,2-b)furan-10,11-dione, 6,7,8,9-tetrahydro-1-methyl-6-methylene-; methylene tanshinquinone; Methylene tanshinquinone; 1-methyl-6-methylene-8,9-dihydro-7H-naphtho[8,7-g]benzofuran-10,11-dione; methylenetanshinquinone C18H14O3 278.3 CC1=COC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCCC4=C
TCMBANKIN029584 sym-homospermidine N-(4-azaniumylbutyl)butane-1,4-bis(aminium); CHEBI:57811; sym-homospermidinium(3+); sym-homospermidinium trication C8H21N3 159.27 g/mol C(CCNCCCCN)CN
TCMBANKIN035920 collettinside i C33H52O8
TCMBANKIN038204 ferulic acid (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate; caffeic acid 3-methyl ether; ferulicacid; A803063; (E)-3-(4-Hydroxy-3-methoxyphenyl)-2-propenoate; CJ-00500; ZB002373; ferulate; CHEBI:29749; (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate; 3-Methoxy-4-hydroxy-trans-cinnamate; (E)-3-(3-methoxy-4-oxidanyl-phenyl)prop-2-enoate; Ferulic Acid; AC1NUT2L; ferulic acid C10H10O4 194.18 COC1=C(C=CC(=C1)C=CC(=O)O)[O-]
TCMBANKIN039439 Tanshinone IIa SCHEMBL4126834; CHEMBL187266; UNII-4GPC9FQG6L; tanshinone II A; Phenanthro[1,2-b]furan-10,11-dione, 6,7,8,9-tetrahydro-1,6,6-trimethyl-; 568T729; BB_NC-1062; HMS1361P19; 17545-07-2; SCHEMBL2026738; CHEBI:108595; FT-0652880; AKOS004120032; MLS006011840; AC-1440; BSPBio_002426; HMS2270D15; SMR000387068; Acid Red 5 sodium salt; CT0134; Tanshinone IIA, >=97% (HPLC); NCGC00095755-03; Tanshinone IIA, United States Pharmacopeia (USP) Reference Standard; ACN-035345; CTK5A5836; Tanshinone IIA, analytical standard; AIDS-150197; s2365; NCGC00095709-01; HMS1791P19; CCG-208275; SC-17279; 1,6,6-Trimethyl-1,2,6,7,8,9-hexahydrophenanthro[1,2-b]furan-10,11-dione-, (R)-; I06-0439; SR-01000758926-4; KBio3_000634; 1,6,6-trimethyl-6,7,8,9-tetrahydrophenanthro[1,2-b]furan-10,11-dion; 6,6,14-trimethyl-12-oxatetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-1(10),2(7),8,11(15),13-pentaene-16,17-dione; Tanshinon II; AC1L4V8J; 4CN-0930; KBio2_000317; HSDB 8104; AN-14938; Tanshinone IIA; RTR-031585; BC205184; BRD-K00141480-001-03-0; AC1LAW3B; TL8003671; NCI60_031209; Phenanthro[1,2-b]furan-10,11-dione, 1,2,6,7,8,9-hexahydro-1,6,6-trimethyl-, (R)-; 6,7,8,9-Tetrahydro-1,6,6-trimethylphenanthro[1,2-b]furan-10,11-dione; SMR004703500; CCG-207955; N1846; (?)-Cryptotanshinone; NCGC00095709-04; Phenanthro[1,11-dione, 6,7,8,9-tetrahydro-1,6,6-trimethyl-; Tanshinone II; 1,6,6-Trimethyl-6,7,8,9-tetrahydrophenanthro[1,2-b]furan-10,11-dione #; HMS3656C11; 1,6,6-Trimethyl-6,7,8,9-tetrahydrophenanthro[1,2-b]furan-10,11-dione; KBioSS_000317; SR-01000758926-2; MCULE-8689433740; NCGC00095709-03; I14-22013; Bio2_000317; NP474; NCGC00095709-02!TANSHINONE IIA; Phenanthro(1,2-b)furan-10,11-dione, 6,7,8,9-tetrahydro-1,6,6-trimethyl-; BC678108; A831217; BBL010026; CTK8I3995; NSC686519; AS-16136; UPCMLD-DP042:001; KBioGR_000317; SBB066119; Dan Shen Ketone; STK801405; SR-01000758926-5; NSC-686519; S594; 1,6,6-trimethyl-2,7,8,9-tetrahydro-1H-naphtho[1,2-g]benzofuran-10,11-dione; BG00628358; Ambotz568-72-9; MFCD00238692; Tanshinone A; InChI=1/C19H20O3/c1-10-9-22-18-12-6-7-13-11(5-4-8-19(13,2)3)15(12)17(21)16(20)14(10)18/h6-7,10H,4-5,8-9H2,1-3H3; BBL028449; Tanshinone B, Tanshinone II, 568-72-9; Tanshinone B; Tanshinone IIA, European Pharmacopoeia (EP) Reference Standard; Cryptotanshinon; CHEMBL1518673; MLS001048863; STK801917; KBio2_005453; TR-031585; MolPort-002-507-310; AC1Q6JLQ; NCGC00095709-05; (-)-Cryptotanshinone; HMS3402P19; NCGC00095709-06; W-2832; SPECTRUM1505824; 4GPC9FQG6L; C19H18O3; Bio2_000797; HMS2089H08; Q-100654; Tanshinone IIa; Cryototanshinone; KBio2_002885; BDBM83922; IDI1_034067; 568-72-9; MLS006011834; BSPBio_001597; DTXSID60205352; GVKKJJOMQCNPGB-UHFFFAOYSA-; HYXITZLLTYIPOF-UHFFFAOYSA-N; 1,6,6-trimethyl-8,9-dihydro-7H-naphtho[1,2-g][1]benzofuran-10,11-dione; HMS1989P19; 6,6,14-trimethyl-12-oxatetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadeca-1,7,9,11(15)-tetraene-16,17-dione; SR-01000758926; BIB6295; NCGC00095709-02; 1,6,6-trimethyl-8,9-dihydro-7H-naphtho[8,7-g]benzofuran-10,11-dione; cid_164676; ZINC01650576; NCGC00095755-01; MFCD05671363; GP2434; 1,6,6-trimethyl-2,7,8,9-tetrahydro-1H-naphtho[1,2-g][1]benzofuran-10,11-dione; 6,6,14-trimethyl-12-oxatetracyclo[8.7.0.02,7.011,15]heptadeca-1(10),2(7),8,11(15),13-pentaene-16,17-dione; Tanshinone IIA (Tanshinone B); LS-175776; 1,6,6-trimethyl-8,9-dihydro-7H-naphtho[8,7-g][1]benzoxole-10,11-dione; HMS3655P20; NSC 686518; I06-0645; tanshinone ii a; Tanshinone 2-A; KBio3_000633; 1,6,6-trimethyl-8,9-dihydro-7H-naphtho[1,2-g]benzofuran-10,11-quinone; UPCMLD-DP042; 1,6,6-trimethyl-8,9-dihydro-7H-naphtho[8,7-g]benzofuran-10,11-quinone; AB0018692; NSC686518; AIDS150197; API0010219; GVKKJJOMQCNPGB-UHFFFAOYSA-N; STOCK1N-48169; HY-N0135; AKOS005612965; 1,6,6-trimethyl-8,9-dihydro-7H-naphtho[1,2-g]benzofuran-10,11-dione; TanshinoneIIA; ZINC1650576; 1,6,6-Trimethyl-1,2,6,7,8,9-hexahydrophenanthro[1,2-b]furan-10,11-dione; Neuro_000424 294.34
TCMBANKIN040061 Przewaquinone B przewaquinone b; 14-(HYDROXYMETHYL)-6-METHYL-12-OXATETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-1(10),2(7),3,5,8,11(15),13-HEPTAENE-16,17-DIONE; 1-(hydroxymethyl)-6-methylnaphtho[1,2-g]benzofuran-10,11-dione; CETREAVXUDHZGK-UHFFFAOYSA-N; AC1LDNAN; 6-methyl-1-methylol-naphtho[1,2-g]benzofuran-10,11-quinone; 1-(Hydroxymethyl)-6-methylphenanthro[1,2-b]furan-10,11-dione; SCHEMBL16152288; 1-(Hydroxymethyl)-6-methylphenanthro[1,2-b]furan-10,11-dione #; 1-(hydroxymethyl)-6-methyl-naphtho[1,2-g]benzofuran-10,11-dione; 1-(hydroxymethyl)-6-methylnaphtho[1,2-g][1]benzofuran-10,11-dione; 76829-01-1; 1-(hydroxymethyl)-6-methylnaphtho[1,2-g][1]benzoxole-10,11-dione; 1-(hydroxymethyl)-6-methyl-naphtho[1,2-g][1]benzoxole-10,11-dione 292.285
TCMBANKIN058260 sulfanilicacid BR-53425; 22484-64-6 (zinc[2:1] salt); TR-034638; 121-57-3; NCGC00090886-02; AN-22849; 4-Sulfanilic acid; Nizin; I05-0157; CHEBI:27500; BC204845; Benzenesulfonic acid, 4-amino-; Sulfanilic acid, United States Pharmacopeia (USP) Reference Standard; 4-Aminobenzenesulfonic acid; SBB028140; Sulfanilic acid, JIS special grade, 99.0-100.5%; AS01575; AC1L1R31; 4-aminobenzene-sulfonic acid; 4-aminobenzene-1-sulfonic acid; Sulfanilic acid, ACS reagent, 99%; EINECS 204-482-5; Sulphanilic acid; p-Aminophenylsulfonic acid; 4-Aminobenzenesulfonic acid; Aniline-4-sulfonic acid; 4-aminophenylsulfonic acid; Sulfanilsaeure; ACMC-1BOZB; ST4084010; M-6005; AB1003505; SULFANILIC ACID TS; 856062-06-1; 434Z8C2635; Benzenesulphonic acid, 4-amino-; Sulfanilic acid, 99%; BBL011603; ANILINE P-SULFONIC ACID; Kyselina sulfanilova [Czech]; Epitope ID:122241; ANW-17754; InChI=1/C6H7NO3S/c7-5-1-3-6(4-2-5)11(8,9)10/h1-4H,7H2,(H,8,9,10; KS-00000V3R; SULFANILIC ACID, ACS; Nitrate Reagent B, for microbiology; Sulfanilic Acid Anhydrous; 1-aminobenzene-4-sulfonic acid; NSC 7170; ZINC1530397; EC 204-482-5; Sulfanilate Zinc (sulfanilic acid); C06335; 4-Aminobenzenesulphonic Acid (Sulphanilic Acid); Kyselina sulfanilova; RP23551; H459; SC-26832; AC1Q51Y7; PubChem20323; KSC175E5L; 28029-EP2314588A1; BDBM50443531; 515-74-2 (hydrochloride salt); Aniline-4-sulfonic acid; Sulfanilic acid, >=99.0%; p-aminobenzene sulfonic acid; Aniline-p-sulfonic acid; UNII-434Z8C2635; SULFANILLIC ACID; LS-650; p-sulphanilic acid; KB-36490; A3126/0132260; SUFANILIC ACID; ST2411105; J-004536; NSC7170; SCHEMBL24407; Aniline-p-sulphonic acid; 4-amino-1-benzenesulfonic acid; P-ANILINE SULFONIC ACID; NSC-7170; NITRATE REAGENT B; p-Anilinesulfonic acid; P-SULFANILIC ACID; sulfanilic acid; CHEMBL1566888; NCGC00090886-01; Sulfanilic acid, 99.0-100.5%, suitable for determination of nitroxide; UKRORGSYN-BB BBR-006490; AC-12565; Sulfanilic acid, Vetec(TM) reagent grade, 99%; BG00601609; CTK0H5255; 4-Sulfoaniline; MolPort-001-783-839; HVBSAKJJOYLTQU-UHFFFAOYSA-N; bmse000726; p-aminobenzenesulphonic acid; Sulfanilsaeure [German]; AI3-15414; 4-Amino-benzenesulfonic acid; LABOTEST-BB LTBB002174; AM91128; AC1Q6WPM; Sulfanilic acid;; MCULE-9573132621; DTXSID6024464; 28029-EP2311809A1; S0120; p-Aminobenzenesulfonic acid; Sulfanilic acid, p.a., 98.0-102.0%; TRA0084520; MFCD00007886; Sulfanilic acid, 98% 250g; aniline-4-sulphonic acid; CCRIS 4576; 4-AMINOBENZENESULPHONIC ACID; TIMTEC-BB SBB028140; STK661383; 4-ANILINESULFONIC ACID; HSDB 5590; 4-Amino benzenesulphonic acid; BB_SC-7049; RTR-034638; SULFANILATE ZINC; AJ-26659; SULFANILIC ACID; Sulfanilic acid, puriss. p.a., >=99.0% (T); AK-53425; Sulfanilic Acid, Pharmaceutical Secondary Standard; Certified Reference Material; F0001-0346; AKOS000118732;Sulfanilsaeure;InChI=1/C6H7NO3S/c7-5-1-3-6(4-2-5)11(8,9)10/h1-4H,7H2,(H,8,9,10; AIDS020178; S5263_SIGMA; p-Aminobenzenesulfonic acid; A3126/0132260; 121-57-3; 86090_FLUKA; NCGC00090886-02; 4-Sulfanilic acid; Sulfanilic acid; NSC7170; NSC 7170; Aniline-p-sulphonic acid; CHEBI:27500; Benzenesulfonic acid, 4-amino-; 4-Aminobenzenesulfonic acid; CCRIS 4576; EINECS 204-482-5; HSDB 5590; p-Aminophenylsulfonic acid; Sulphanilic acid; NCGC00090886-01; C06335; AIDS-020178; Sulfanilsaeure [German]; AI3-15414; 251917_SIAL; Aniline-4-sulfonic acid; Kyselina sulfanilova [Czech]; Aniline-p-sulfonic acid C6H7NO3S 173.19 g/mol C1=CC(=CC=C1N)S(=O)(=O)O
TCMBANKIN059165 isomicropinic acid;sugiol (4aS)-6-hydroxy-1,1,4a-trimethyl-7-propan-2-yl-3,4,10,10a-tetrahydro-2H-phenanthren-9-one; AC1NT0MY; 7-carbonyl-12-hydroxy-dehydroabietane; 1,1,4abeta-Trimethyl-6-hydroxy-7-isopropyl-1,2,3,4,4a,9,10,10a-octahydrophenanthrene-9-one; SCHEMBL17407685 C20H28O2 300.44 CC(C)C1=C(C=C2C(=C1)C(=O)CC3C2(CCCC3(C)C)C)O
TCMBANKIN059167 C09092 ACon1_000701; MEGxp0_000699; (4bS,8aS)-2-isopropyl-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-3-ol; (4bS,8aS)-4b,8,8-trimethyl-2-propan-2-yl-5,6,7,8a,9,10-hexahydrophenanthren-3-ol; 514-62-5; ferruginol; 8,11,13-abietatrien-12-ol; erruginol; (+)-8,11,13-abietatrien-12-ol; AC1LAVG6; SCHEMBL5315022; ferruginol ; 4b,8,8-trimethyl-2-propan-2-yl-5,6,7,8a,9,10-hexahydrophenanthren-3-ol; 4CN-1292; Abieta-9(11),8(14),12-trien-12-ol; AC1LAVG6; SCHEMBL5315022; ferruginol ; 4b,8,8-trimethyl-2-propan-2-yl-5,6,7,8a,9,10-hexahydrophenanthren-3-ol; 4CN-1292; Abieta-9(11),8(14),12-trien-12-ol C20H30O 286.5 g/mol CC(C)C1=C(C=C2C(=C1)CCC3C2(CCCC3(C)C)C)O
TCMBANKIN059815 tanshinone i C18H12O3 276.3 g/mol CC1=C2C=CC3=C(C2=CC=C1)C(=O)C(=O)C4=C3OC=C4C
TCMBANKIN060525 coleonolic acid;hyptadienic acid C30H46O4 CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(C(=CC5(C)C)CO)C)C)C2C1(C)O)C)C(=O)O
TCMBANKIN060529 Tormentic acid C30H48O5 488.7 g/mol CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)O)O)C)C)C2C1(C)O)C)C(=O)O
TCMBANKIN060532 corosolic acid C30H48O4 472.7 g/mol CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)O)O)C)C)C2C1C)C)C(=O)O
TCMBANKIN060537 Euscaphic acid 3,4-monoacetonide C30H48O5 488.7 CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC6C(C5(C)C)OC(O6)(C)C)C)C)C2C1(C)O)C)C(=O)O
TCMBANKIN060615 dihydrotanshinone i C18H14O3 278.3 g/mol CC1COC2=C1C(=O)C(=O)C3=C2C=CC4=C(C=CC=C43)C
   植物对应的疾病
疾病ID 病名 疾病类型 MeSH 参考文献
   植物对应的靶点
靶点ID 基因名 基因别名 描述 染色体位置 Map_Location 基因类型

Home | Browse | Search | Predict | Data | Contact | Help

Copyright © KUST | 滇ICP备16009434号-1 | Dai SX Lab